I'm Joe Gradyton and I'm Terry Grady. Welcome to this podcast of the People's Pharmacy.

You can find previous podcasts and more information on a range of health topics at people's Pharmacy.com.

Shakespeare's credited with the phrase,

The eyes are the window to the soul.

Are they also the window to the brain?

This is the People's Pharmacy with Terry and Joe Grady. Our guest in the studio today is a retinal specialist. She studies how the

retina reveals what's happening in the brain? She'll also answer your questions about eye health.

Are you concerned about the epidemic of myopia in children?

What about macular degeneration or glaucoma.

Dry eyes are common, but there's been controversy about the safety of some over-the-counter generic

eye drops.

Coming up on the People's Pharmacy, we'll take your calls about how to keep your eyes healthy. In the People's Pharmacy Health Headlines, the FDA has just approved the first novel drug treatment for schizophrenia in decades.

Kobenfi, also known as CARXT, is a combination of two medications.

Xenomoline and Trospium.

What makes this drug different is its mechanism of action.

Unlike conventional antipsychotic medications like chloropromesine or olansopine,

Kobanfi works through receptors for the neurotransmitter acetyl-Coline.

This means it's less likely to cause the most troublesome side effects of previous drugs.

They work directly through an effect on dopamine. Many people find these older medicines difficult to tolerate because they can cause movement disorders, irregular heart rhythms, brain fog, diabetes, high cholesterol, or weight gain.

The new antipsychotic medication has some adverse effects, heartburn, nausea, vomiting,

stomach pain, nausea, vomiting, stomach pain,

high blood pressure, dizziness, and urinary retention.

...